“Regenerative Medicine Crossroad® in Tokyo #10” on September 25, 2019, Tokyo, Japan
– A Can’t-miss Opportunity to Meet Your Business Partners in Japan –
The ISCT North America 2019 Regional Meeting will showcase a curated program highlighting how the latest research, clinical applications, and manufacturing developments are Engineering the Future of Cell and Gene Therapies. The 2.5 day program will feature cutting-edge plenary sessions, concurrent workshops, meet the experts sessions, and oral abstract and poster presentations.
A series of screenings from DISORDER: The Rare Disease Film Festival will be shown as part of Biotech Week Boston. The screenings aim to build connections between the biopharma community, patient advocacy groups, patients, and those who are passionate about finding cures for those living with rare diseases, which may ultimately lead to new paths for research.
DISORDER: The Rare Disease Film Festival showcases a curated lineup of films addressing the challenges and struggles of patients, and their families, living with a rare disease face on a day-to-day basis. These films put the often abstract and dire clinical information into the context of real people living their lives.
Join us to explore the challenges, hopes, and inspiration that come from these films.
The goal of this Cell Symposium is to bring scientists studying organoids and organ engineering together with bioengineers to discuss the exciting opportunities and challenges for engineering complexity in higher-order organ-like systems and to foster collaborations and synergize efforts toward generating cellular platforms that can address a myriad of unmet needs.
Symposium topics:
5-day Advanced Industrial Bioprocessing professional short course at UMass Lowell. The course will be taught by industry professionals from BMS, Pfizer, MilliporeSigma, and UMass experts.
This new GRC will feature the most exciting work on molecular, cellular and systems-level changes that affect the injured spinal cord and influence neural repair. Cutting edge discoveries in the injured and regenerating transcriptome, the epigenome, neurons, glia and the immune system will be explored in a highly interactive and in-depth format of discussion and debate. The goal is to collectively accelerate discovery and translation of treatments that will lead to functional recovery. We welcome participation from basic scientists, clinicians and industry.
The Harvard Stem Cell Institute invites you to join the 12th annual Business of Regenerative Medicine conference at Harvard Business School. Our theme this year is Defining and Creating Value.
Over two days of panel discussions, presentations, and networking, our distinguished speakers will provide insights – as well as guardrails – for navigating the emerging industry of regenerative medicine.
We will explore how advances in cell and gene therapy, drug development, and bioengineering in regenerative medicine are moving from the lab to the patient – and what it will take to identify real, lasting value for business and society.
